| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Hari Shanker Bhartia B.E., B.Tech CEO | XNSE Exchange | INE0BY001018 ISIN |
| IN Country | 2,139 Employees | 24 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Jubilant Ingrevia Limited is a multifaceted company that excels in the provision of life science products and solutions both within India and internationally. Functioning through three primary segments—Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates—Jubilant Ingrevia has established itself as a leader in its field. Initially known as Jubilant LSI Limited, the company underwent a name change to Jubilant Ingrevia Limited in October 2020, marking a new chapter in its journey since its incorporation in 2019. With its headquarters in Noida, India, Jubilant Ingrevia serves a diverse range of industries including pharmaceuticals, animal and human nutrition, agrochemicals, personal and consumer care, and various industrial sectors.
Jubilant Ingrevia Limited offers an extensive array of products and services categorized under three main segments:
In addition to these products, Jubilant Ingrevia Limited offers an array of specialized chemicals such as cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, dione salts, alkyl pyridines, vitamin B3, Vitamin B4, picolinates, riboflavin phosphate sodium, and nutritional premixes. The company also features antioxidants, straight ingredients for nutrition, various animal nutrition products like toxin binders, acidifiers, enzymes, and emulsifiers, highlighting its versatility and capacity to meet a wide array of customer needs. Furthermore, Jubilant Ingrevia is involved in route design, process development, optimization, and scale-up and commercial manufacturing of intermediates, showcasing its comprehensive approach to chemical manufacturing and pharmaceuticals.